biotech · Coronary Artery Disease · Bronchopulmonary Dysplasia · ASBP
Aspire Biopharma Holdings
Aspire Biopharma is a biotech organization headquartered in Humacao, USA. It trades on NYSE under ticker ASBP. Primary therapeutic focus areas include Coronary Artery Disease, Bronchopulmonary Dysplasia, Heart Failure, C
Humacao, USA HQ
2019 Founded
Public company Type
ASBP · NYSE Ticker
Company details
- Status
- Public
- HQ
- Humacao, USA
- Founded
- 2019
- Programs
- 8
- Drugs
- 8
- Patents
- 1
Pulse Sequence
Approved · other · Atrial Fibrillation
Pulse Sequence for Atrial Fibrillation is a Approved program (other) at Aspire Biopharma Holdings with 1 ClinicalTrials.gov record(s).
Internal code 16-044
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Aspire Biopharma Holdings
- Phase
- Approved
- Modality
- other
- Indication
- Atrial Fibrillation
- Status
- completed
- Trials
- 1